PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Vyome Holdings, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Vyome Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 86% of Healthcare companies in United States.

Where $100 of sales goes

$959Operating costs$46Interest$3,210Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 16%

Sales fell 16% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-16% / +263%

In 3 years sales changed by -16% while total assets changed by +263%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-119.9×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 86% of Healthcare companies in United States.

Cash Cushion Ratio

+39%

Cash, after subtracting all debt, equals 39% of its market value (net cash).

Higher than 74% of Healthcare companies in United States.

Tangible Assets Ratio

95%

Of every $100 the company owns, $95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 73% of Healthcare companies in United States.

Tangible Net Worth Ratio

87%

Of every $100 of net worth, $87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 68% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

−78%

Share count fell 78% in 3 years (buybacks), so each share's slice of the company became larger.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Vyome Holdings, Inc. owes $0.20 for every $1 it owns. Vyome Holdings, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

1.0

Investors pay $1.0 for every $1 of Vyome Holdings, Inc.'s yearly profit, lower than 92% of Healthcare companies in United States.

P/B ratio

2.09

The share price is 2.09 times Vyome Holdings, Inc.'s book value per share, lower than 57% of Healthcare companies in United States.

Market cap

$13 M

The total market value of all of Vyome Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 85% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$6 M

What Vyome Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.86

Net worth divided by the number of shares. The share price of $1.80 is 2.1 times this, which is the P/B above.

Return on equity (ROE)

-999.2%

Vyome Holdings, Inc. lost 999.2% of its shareholders' money over the last year, lower than 98% of Healthcare companies in United States.

Owes vs Owns

0.20×

Vyome Holdings, Inc. owes $0.20 for every $1 it owns (low), lower than 71% of Healthcare companies in United States.

Dividend yield

None

Vyome Holdings, Inc. does not currently pay a dividend.

Revenue growth

+24%

Revenue rose 24% in the year to Dec 2025, and shrank 6% a year on average over 3 years.

Profit growth

Loss

Vyome Holdings, Inc. made a loss in each of the last two years.

Profit margin

-3209.7%

Vyome Holdings, Inc. lost $3210 for every $100 of revenue.

Interest cover

Not covered

Vyome Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Vyome Holdings, Inc. held $5 M more cash than debt (net cash) at Dec 2025.

Questions

What is Vyome Holdings, Inc.'s P/E ratio?

Investors pay $1.0 for every $1 of Vyome Holdings, Inc.'s yearly profit, lower than 92% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Vyome Holdings, Inc.: $13 M ÷ $6 M (30 Jun 2026) = 2.1.

What is Vyome Holdings, Inc.'s return on equity?

Vyome Holdings, Inc. lost 999.2% of its shareholders' money over the last year, lower than 98% of Healthcare companies in United States.

How much does Vyome Holdings, Inc. owe compared with what it owns?

Vyome Holdings, Inc. owes $0.20 for every $1 it owns (low), lower than 71% of Healthcare companies in United States.

Does Vyome Holdings, Inc. pay a dividend?

No. Vyome Holdings, Inc. does not currently pay a dividend.

Is Vyome Holdings, Inc.'s revenue growing?

Revenue rose 24% in the year to Dec 2025, and shrank 6% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.